Rationale and study design of the CHIPPI-1808 trial: a phase III randomized clinical trial evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) for stage III ovarian cancer patients treated with primary or interval cytoreductive surgery -
BEVACIZUMAB IN OVARIAN CANCER: Phase III Trial -Clinical Trials Ongoing | Download Table
Ovarian cancer clinical trials involving miRs. | Download Table
![PDF] Current and future directions of clinical trials for ovarian cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7f15aa00fe070d53cbd782ae6153a6a322dec4f1/4-Figure2-1.png "PDF] Current and future directions of clinical trials for ovarian cancer. | Semantic Scholar")
PDF] Current and future directions of clinical trials for ovarian cancer. | Semantic Scholar
Clinical trials results for PARP Inhibitors in ovarian cancer. | Download Table
An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor - Gynecologic
Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome - European Journal of Cancer
Fact Sheet Ovarian Cancer Clinical Trial - BioCanRx
Recurrent Epithelial Ovarian Cancer: An Update on Treatment
Breast and Ovarian Cancer Clinical Trials
Promising treatment for ovarian cancer reaches final stages of clinical trials
BEVACIZUMAB IN OVARIAN CANCER -Clinical Trials Ongoing | Download Table
Ovarian Cancer | Symptoms, Diagnosis & Treatment | MD Anderson Cancer Center
![CLINICAL TRIALS [GANNET53]](http://www.gannet53.eu/_media/concept_of_eudario.png "CLINICAL TRIALS [GANNET53]")
CLINICAL TRIALS [GANNET53]
Upcoming Clinical Trials for Ovarian Cancer
Current status and future prospects of PARP inhibitor clinical trials | CMAR
Ovarian cancer clinical trial workflow. Fig 1 depicts an overview on... | Download Scientific Diagram
Mucinous Ovarian Carcinoma | NEJM
Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial - The Lancet
Tools in the pharmacologic arsenal for treatment of ovarian cancer.... | Download Scientific Diagram
Ovarian Cancer | Patient Care
Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline - Gynecologic Oncology
Prediction of the treatment response in ovarian cancer: a ctDNA approach | Journal of Ovarian Research | Full Text
JCI Insight - Phase II clinical trial of metformin as a cancer stem cell–targeting agent in ovarian cancer
